lifemd is a comprehensive one-stop telemedicine/telehealth solution with a platform that provides a fully integrated telehealth solution to connect physicians, medical providers, pharmacists, and patients worldwide. the platform is hipaa-compliant and all interactions and communication between physicians, healthcare providers and patients are aes-encrypted. the platform allows physicians, healthcare providers and patients to securely connect and manage common medical conditions. lifemd also custom fabricates mobile diagnostic telehealth equipment such as cases, carts and kiosks. the service is available 24/7/365.
Company profile
Ticker
LFMD, LFMDP
Exchange
Website
CEO
Justin Schreiber
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CONVERSION LABS, INC., Immudyne, Inc.
SEC CIK
Corporate docs
Subsidiaries
WorkSimpli Software LLC • Springbox Technologies LLC • Taylor Technologies Inc ...
LFMD stock data
Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
8 May 24
8-K
LifeMD Appoints Dr. Calum MacRae to its Board of Directors
2 May 24
ARS
2023 FY
Annual report to shareholders
29 Apr 24
DEFA14A
Additional proxy soliciting materials
29 Apr 24
DEF 14A
Definitive proxy
29 Apr 24
S-8
Registration of securities for employees
15 Mar 24
10-K
2023 FY
Annual report
11 Mar 24
S-8
Registration of securities for employees
21 Dec 23
8-K
LifeMD and Medifast Partner to Offer Transformative Weight Management Solution
13 Dec 23
8-K
Departure of Directors or Certain Officers
14 Nov 23
Transcripts
LFMD
Earnings call transcript
2024 Q1
8 May 24
LFMD
Earnings call transcript
2023 Q4
11 Mar 24
LFMD
Earnings call transcript
2023 Q3
8 Nov 23
LFMD
Earnings call transcript
2023 Q2
9 Aug 23
LFMD
Earnings call transcript
2023 Q2
9 Aug 23
LFMD
Earnings call transcript
2023 Q1
12 May 23
LFMD
Earnings call transcript
2023 Q1
22 Mar 23
LFMD
Earnings call transcript
2022 Q3
11 Nov 22
LFMD
Earnings call transcript
2022 Q2
11 Aug 22
LFMD
Earnings call transcript
2022 Q1
13 May 22
Latest ownership filings
4
NAVEEN BHATIA
5 Apr 24
4
Eric Harold Yecies
25 Mar 24
4
MARIA E. STAN
25 Mar 24
4
Stefan Galluppi
25 Mar 24
4
Marc David Benathen
25 Mar 24
4
Nicholas P Alvarez
25 Mar 24
4
NAVEEN BHATIA
14 Mar 24
SC 13G/A
Divisadero Street Capital Management, LP
14 Feb 24
4
Justin Schreiber
15 Nov 23
4
Piyush Jindal
8 Nov 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 15.29 mm | 15.29 mm | 15.29 mm | 15.29 mm | 15.29 mm | 15.29 mm |
Cash burn (monthly) | (no burn) | (no burn) | 1.52 mm | 1.89 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 11.22 mm | 13.93 mm | n/a | n/a |
Cash remaining | n/a | n/a | 4.07 mm | 1.36 mm | n/a | n/a |
Runway (months of cash) | n/a | n/a | 2.7 | 0.7 | n/a | n/a |
Institutional ownership, Q4 2023
12.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 8 |
Opened positions | 2 |
Closed positions | 57 |
Increased positions | 1 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 226.18 mm |
Total shares | 4.89 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Divisadero Street Capital Management | 1.92 mm | $11.62 mm |
Stefan Galluppi | 1.65 mm | $0.00 |
Integrated Core Strategies | 1.27 mm | $12.35 mm |
Sowa Financial | 25.00 k | $207.00 k |
Raymond James Financial Services Advisors | 20.92 k | $173.43 mm |
HighMark Wealth Management | 3.00 k | $24.87 mm |
Centerpoint Advisors | 500.00 | $4.00 k |
Focused Wealth Management | 447.00 | $3.71 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Apr 24 | Naveen Bhatia | Common Stock | By will or laws of descent | Acquire W | No | No | 0 | 500 | 0.00 | 488,599 |
21 Mar 24 | Nicholas P Alvarez | Common Stock | Grant | Acquire A | No | No | 0 | 75,000 | 0.00 | 405,000 |
21 Mar 24 | Marc David Benathen | Common Stock | Grant | Acquire A | No | No | 0 | 75,000 | 0.00 | 302,554 |
21 Mar 24 | Stefan Galluppi | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 42,449 |
21 Mar 24 | Maria E. Stan | Common Stock | Grant | Acquire A | No | No | 0 | 20,000 | 0.00 | 28,125 |
News
HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $12 Price Target
10 May 24
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
9 May 24
Cantor Fitzgerald Maintains Overweight on LifeMD, Raises Price Target to $15
9 May 24
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
9 May 24
LifeMD Q1 2024 Adj EPS $0.01 Beats $(0.15) Estimate, Sales $44.144M Beat $42.540M Estimate
8 May 24